Westend Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Sell |
10,530
-599
| -5% | -$111K | 0.6% | 24 |
|
|
2025
Q1 | $2.33M | Buy |
11,129
+11,097
| +34,678% | +$2.33M | 0.89% | 23 |
|
|
2024
Q4 | $5.69K | Hold |
32
| – | – | ﹤0.01% | 154 |
|
|
2024
Q3 | $6.32K | Hold |
32
| – | – | ﹤0.01% | 153 |
|
|
2024
Q2 | $5.45K | Sell |
32
-53
| -62% | -$9.03K | ﹤0.01% | 136 |
|
|
2024
Q1 | $15.5K | Buy |
+85
| New | +$15.5K | 0.01% | 103 |
|
|
2016
Q2 | – | Sell |
-5,675
| Closed | -$324K | – | 65 |
|
|
2016
Q1 | $324K | Buy |
5,675
+1,585
| +39% | +$90.5K | 0.44% | 46 |
|
|
2015
Q4 | $242K | Sell |
4,090
-1,675
| -29% | -$99.1K | 0.33% | 51 |
|
|
2015
Q3 | $326K | Buy |
5,765
+665
| +13% | +$37.6K | 0.41% | 49 |
|
|
2015
Q2 | $347K | Buy |
5,100
+645
| +14% | +$43.9K | 0.4% | 49 |
|
|
2015
Q1 | $274K | Buy |
4,455
+2,130
| +92% | +$131K | 0.32% | 53 |
|
|
2014
Q4 | $152K | Buy |
2,325
+1,975
| +564% | +$129K | 0.18% | 51 |
|
|
2014
Q3 | $19K | Buy |
+350
| New | +$19K | 0.02% | 71 |
|
|
2014
Q1 | – | Sell |
-350
| Closed | -$18K | – | 49 |
|
|
2013
Q4 | $18K | Buy |
+350
| New | +$18K | 0.02% | 77 |
|
|
2013
Q2 | $14K | Buy |
+350
| New | +$14K | 0.01% | 85 |
|